Correlation Between Eliem Therapeutics and Iovance Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Iovance Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Iovance Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Iovance Biotherapeutics, you can compare the effects of market volatilities on Eliem Therapeutics and Iovance Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Iovance Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Iovance Biotherapeutics.
Diversification Opportunities for Eliem Therapeutics and Iovance Biotherapeutics
0.15 | Correlation Coefficient |
Average diversification
The 3 months correlation between Eliem and Iovance is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Iovance Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iovance Biotherapeutics and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Iovance Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iovance Biotherapeutics has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Iovance Biotherapeutics go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Iovance Biotherapeutics
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 1.18 times more return on investment than Iovance Biotherapeutics. However, Eliem Therapeutics is 1.18 times more volatile than Iovance Biotherapeutics. It trades about 0.03 of its potential returns per unit of risk. Iovance Biotherapeutics is currently generating about 0.03 per unit of risk. If you would invest 298.00 in Eliem Therapeutics on August 31, 2024 and sell it today you would earn a total of 6.00 from holding Eliem Therapeutics or generate 2.01% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 99.47% |
| Values | Daily Returns |
Eliem Therapeutics vs. Iovance Biotherapeutics
Performance |
| Timeline |
| Eliem Therapeutics |
| Iovance Biotherapeutics |
Eliem Therapeutics and Iovance Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Iovance Biotherapeutics
The main advantage of trading using opposite Eliem Therapeutics and Iovance Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Iovance Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iovance Biotherapeutics will offset losses from the drop in Iovance Biotherapeutics' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |